Analyst Ratings for Jasper Therapeutics (JSPR)
JSPR Rating Summary
JSPR Price Target Summary
- Highest: $20.00 (H.C. Wainwright)
- Lowest: $1.50 (UBS)
- Average: $8.25
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$8.25 (+1618.8%)
* Over Last 12-Mos
Rating Score: 6.9 / 10
Percentile Rank: 73%
Avg. $ Target:
$8.25 (+1618.8%)
* Over Last 12-Mos
Rating Score: 6.9 / 10
Percentile Rank: 73%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/14/2026 | William Blair | N/A | New Coverage | Outperform (N/A) |
N/A (N/A) |
0.50 (0.48) |
-4% | Details |
| 8/12/2026 | Piper Sandler | Biren Amin | New Coverage | Overweight (N/A) |
2.00 (N/A) |
0.80 (0.48) |
-40% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
